Study #PA18-1012
A prospective lab study to detect cytogenetically abnormal cells in patients with lesions or masses suspicious for primary lung cancer.
MD Anderson Study Status
Enrolling
Treatment Agent
Description
A prospective lab study to detect cytogenetically abnormal cells in patients with lesions or masses suspicious for primary lung cancer.
Resources and Links
Phone Number: 1-877-MDA-6789
clinicaltrials.gov NCT No: N/A
Information and next steps
Disease:
Study phase:
Not applicable
Physician name:
Joshua Kuban
Department:
Interventional Radiology
For general questions about clinical trials:
1-877-632-6789
Help #EndCancer
Give Now
Your gift will help make a tremendous difference.
Donate Blood
Our patients depend on blood and platelet donations.
Shop MD Anderson
Show your support for our mission through branded merchandise.